Immunosuppressive drugs and their aerosol delivery for COVID-19 treatment
Despite numerous efforts of healthcare, the incidence of COVID-19 and its fatal complications remains unacceptably high. As COVID-19 pathophysiology is notable for an uncurbed immune response, its treatment protocols routinely include immunosuppressive drugs such as corticosteroids, cytostatic drugs...
Saved in:
| Main Author: | V. I. Kobylyansky |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Kemerovo State Medical University
2022-10-01
|
| Series: | Фундаментальная и клиническая медицина |
| Subjects: | |
| Online Access: | https://fcm.kemsmu.ru/jour/article/view/575 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modification of immunosuppressive agents in a kidney transplant recipient with COVID-19 and acute kidney injury
by: Thanawat Vongchaiudomchoke, et al.
Published: (2021-09-01) -
Approaches to correction of immunosuppressive therapy in chronic nephrotoxicity of calcineurin inhibitors
by: E. S. Stolyarevich, et al.
Published: (2018-08-01) -
Changes in glomerular filtration rate in liver recipients after reduced exposure to calcineurin inhibitors with concomitant everolimus administration within the first year after immunosuppression conversion
by: V. E. Syutkin, et al.
Published: (2022-01-01) -
Editorial: Purinergic signaling in metabolic diseases and inflammation pharmacology
by: Alejandro Sánchez-Melgar, et al.
Published: (2025-06-01) -
A case report of surgical complications in a patient with ulcerative colitis
by: P. Yu. Turkin, et al.
Published: (2023-11-01)